These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 18990567

  • 1. Rational design of novel glycomimetics: inhibitors of concanavalin A.
    Welch KT, Turner TA, Preast CE.
    Bioorg Med Chem Lett; 2008 Dec 15; 18(24):6573-5. PubMed ID: 18990567
    [Abstract] [Full Text] [Related]

  • 2. Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design.
    Liang GB, Qian X, Biftu T, Singh S, Gao YD, Scapin G, Patel S, Leiting B, Patel R, Wu J, Zhang X, Thornberry NA, Weber AE.
    Bioorg Med Chem Lett; 2008 Jul 01; 18(13):3706-10. PubMed ID: 18524582
    [Abstract] [Full Text] [Related]

  • 3. Discovery of novel inhibitors of Trypanosoma cruzi trans-sialidase from in silico screening.
    Neres J, Brewer ML, Ratier L, Botti H, Buschiazzo A, Edwards PN, Mortenson PN, Charlton MH, Alzari PM, Frasch AC, Bryce RA, Douglas KT.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):589-96. PubMed ID: 19144516
    [Abstract] [Full Text] [Related]

  • 4. Identification of novel inhibitors of extracellular signal-regulated kinase 2 based on the structure-based virtual screening.
    Park H, Bahn YJ, Jeong DG, Woo EJ, Kwon JS, Ryu SE.
    Bioorg Med Chem Lett; 2008 Oct 15; 18(20):5372-6. PubMed ID: 18835158
    [Abstract] [Full Text] [Related]

  • 5. Functional evaluation of carbohydrate-centred glycoclusters by enzyme-linked lectin assay: ligands for concanavalin A.
    Köhn M, Benito JM, Ortiz Mellet C, Lindhorst TK, García Fernández JM.
    Chembiochem; 2004 Jun 07; 5(6):771-7. PubMed ID: 15174159
    [Abstract] [Full Text] [Related]

  • 6. Crystal structure of a lectin from Canavalia maritima (ConM) in complex with trehalose and maltose reveals relevant mutation in ConA-like lectins.
    Delatorre P, Rocha BA, Gadelha CA, Santi-Gadelha T, Cajazeiras JB, Souza EP, Nascimento KS, Freire VN, Sampaio AH, Azevedo WF, Cavada BS.
    J Struct Biol; 2006 Jun 07; 154(3):280-6. PubMed ID: 16677825
    [Abstract] [Full Text] [Related]

  • 7. Discovering new inhibitors of bacterial glucosamine-6P synthase (GlmS) by docking simulations.
    Floquet N, Richez C, Durand P, Maigret B, Badet B, Badet-Denisot MA.
    Bioorg Med Chem Lett; 2007 Apr 01; 17(7):1966-70. PubMed ID: 17291748
    [Abstract] [Full Text] [Related]

  • 8. Dynamic combinatorial carbohydrate libraries: probing the binding site of the concanavalin A lectin.
    Ramström O, Lohmann S, Bunyapaiboonsri T, Lehn JM.
    Chemistry; 2004 Apr 02; 10(7):1711-5. PubMed ID: 15054758
    [Abstract] [Full Text] [Related]

  • 9. Amino acid sequence and tertiary structure of Cratylia mollis seed lectin.
    De Souza GA, Oliveira PS, Trapani S, Santos AC, Rosa JC, Laure HJ, Faça VM, Correia MT, Tavares GA, Oliva G, Coelho LC, Greene LJ.
    Glycobiology; 2003 Dec 02; 13(12):961-72. PubMed ID: 12966038
    [Abstract] [Full Text] [Related]

  • 10. Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.
    Furet P, Schoepfer J, Radimerski T, Chène P.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4014-7. PubMed ID: 19560355
    [Abstract] [Full Text] [Related]

  • 11. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H, Li M, Choi J, Cho H, Ham SW.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4372-5. PubMed ID: 19500977
    [Abstract] [Full Text] [Related]

  • 12. The rational design of inhibitors of nitric oxide formation by inducible nitric oxide synthase.
    Whitlow M, Adler M, Davey D, Huang Q, Koovakkat S, Parkinson JF, Pham E, Polokoff M, Xu W, Yuan S, Phillips G.
    Bioorg Med Chem Lett; 2007 May 01; 17(9):2505-8. PubMed ID: 17336523
    [Abstract] [Full Text] [Related]

  • 13. Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.
    Moreau F, Desroy N, Genevard JM, Vongsouthi V, Gerusz V, Le Fralliec G, Oliveira C, Floquet S, Denis A, Escaich S, Wolf K, Busemann M, Aschenbrenner A.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):4022-6. PubMed ID: 18571407
    [Abstract] [Full Text] [Related]

  • 14. Manganese(II) in concanavalin A and other lectin proteins.
    Kalb AJ, Habash J, Hunter NS, Price HJ, Raftery J, Helliwell JR.
    Met Ions Biol Syst; 2000 Jul 15; 37():279-304. PubMed ID: 10693137
    [No Abstract] [Full Text] [Related]

  • 15. Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.
    Dodd DS, Sheriff S, Chang CJ, Stetsko DK, Phillips LM, Zhang Y, Launay M, Potin D, Vaccaro W, Poss MA, McKinnon M, Barrish JC, Suchard SJ, Murali Dhar TG.
    Bioorg Med Chem Lett; 2007 Apr 01; 17(7):1908-11. PubMed ID: 17291752
    [Abstract] [Full Text] [Related]

  • 16. Molecular modelling of protein-carbohydrate interactions. Docking of monosaccharides in the binding site of concanavalin A.
    Imberty A, Hardman KD, Carver JP, Pérez S.
    Glycobiology; 1991 Dec 01; 1(6):631-42. PubMed ID: 1822243
    [Abstract] [Full Text] [Related]

  • 17. Structural basis of functional mimicry between carbohydrate and peptide ligands of con A.
    Jain D, Kaur KJ, Goel M, Salunke DM.
    Biochem Biophys Res Commun; 2000 Jun 16; 272(3):843-9. PubMed ID: 10860840
    [Abstract] [Full Text] [Related]

  • 18. Beyond carbohydrate binding: new directions in plant lectin research.
    Komath SS, Kavitha M, Swamy MJ.
    Org Biomol Chem; 2006 Mar 21; 4(6):973-88. PubMed ID: 16525538
    [Abstract] [Full Text] [Related]

  • 19. N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.
    Barf T, Lehmann F, Hammer K, Haile S, Axen E, Medina C, Uppenberg J, Svensson S, Rondahl L, Lundbäck T.
    Bioorg Med Chem Lett; 2009 Mar 15; 19(6):1745-8. PubMed ID: 19217286
    [Abstract] [Full Text] [Related]

  • 20. Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.
    Cook BN, Bentzien J, White A, Nemoto PA, Wang J, Man CC, Soleymanzadeh F, Khine HH, Kashem MA, Kugler SZ, Wolak JP, Roth GP, De Lombaert S, Pullen SS, Takahashi H.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):773-7. PubMed ID: 19111460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.